Clinical trial
The HIT-TRAP Trial
NCT00196417 · University Medicine Greifswald, Other · Unknown status
Key facts
| NCT number | NCT00196417 |
|---|---|
| Title | The HIT-TRAP Trial |
| Official title | Randomized-Double Blind Trial to Assess the Incidence and Clinical Relevance of Heparin-Induced Thrombocytopenia (HIT) Antibodies in Trauma Patients Treated With Unfractionated or Low-Molecular Weight Heparin, the HIT-TRAP Trial |
| Lead sponsor | University Medicine Greifswald, Other |
| Collaborators | Novartis Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Heparin-Induced Thrombocytopenia |
| Intervention type | Drug |
| Interventions | Standard heparin (UFH) versus certoparin (LMWH) |
| Enrollment | 600 |
| Start date | Jan 1, 2003 |
| Completion | Nov 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Sep 20, 2005 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: